Humanized docking system for assembly of targeting drug delivery complexes

Area of Science:

• Biotechnology
• Molecular Biology
• Drug Delivery Systems

Background:

• Targeted drug delivery necessitates efficient loading of therapeutic agents onto targeting proteins.
• Conventional methods often involve chemical conjugation, which can be complex and potentially alter protein function.
• An alternative approach using non-covalent interactions for complex assembly is desirable.

Purpose of the Study:

• To develop and characterize a novel, fully humanized docking system for targeted drug delivery.
• To utilize non-covalent interactions between engineered protein fragments for assembling targeting complexes.
• To evaluate the efficacy of this system in receptor-mediated DNA delivery.

Main Methods:

• Engineering and expression of human pancreatic RNase I fragments as docking tags and adapter proteins.
• Fusion of an RNase I docking tag to human vascular endothelial growth factor (VEGF) as the targeting protein.
• Characterization of protein interactions using enzymatic assays and surface plasmon resonance (SPR).
• Assembly and characterization of DNA delivery complexes using dynamic light scattering (DLS).

Main Results:

• Successful engineering of active RNase I fragments for docking and adapter functions.
• Demonstration of specific non-covalent interactions between the docking tag and adapter proteins.
• Formation of stable DNA delivery complexes with effective receptor-mediated delivery capabilities.
• High efficiency observed in receptor-mediated DNA delivery using the assembled complexes.

Conclusions:

• A fully humanized, non-covalent docking system based on RNase I fragments is feasible for targeted drug delivery.
• This system offers a promising alternative to chemical conjugation for assembling targeting complexes.
• The developed system demonstrates significant potential for efficient receptor-mediated delivery of therapeutic payloads, such as DNA.